20.04.2012
- Roche dropped its bid to buy the gene-sequencing leader Illumina this week after Illumina's shareholders made it clear at the company's annual meeting that the terms were...
12.04.2012
- Swiss drugmaker Roche dangled the prospect of a higher offer before reluctant U.S. bid target Illumina on Thursday along with broadly flat first-quarter sales supported by its top...
04.04.2012
- Roche stepped up pressure on Illumina shareholders in its battle to take over the U.S. gene sequencing company, telling them in a letter that its increased $6.7 billion bid...
